Upfront Thrombus Aspiration in Primary Coronary Intervention for Patients With ST-Segment Elevation Acute Myocardial Infarction. Report of the VAMPIRE (VAcuuM asPIration thrombus REmoval) Trial

JACC: Cardiovascular Interventions

Volumn 1, Issue 4, 2008, Pages 424-431

  Ikari, Yuji ^a   Sakurada, Masami ^b   Kozuma, Ken ^c   Kawano, Shigeo ^d   Katsuki, Takaaki ^e   Kimura, Kazuo ^f   Suzuki, Takahiko ^g   Yamashita, Takehiro ^h   Takizawa, Akinori ⁱ   Misumi, Kazuo ^j   Hashimoto, Hideki ^k   Isshiki, Takaaki ^c  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Tokorozawa Heart Clinic   (Japan)

^c TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Sakurabashi Watanabe Hospital   (Japan)

^e JICHI MEDICAL UNIVERSITY   (Japan)

^f YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^g Toyohashi Heart Center Toyohashi   (Japan)

^h Hokkaido Ohno Hospital   (Japan)

ⁱ SHIZUOKA CITY SHIMIZU HOSPITAL   (Japan)

^j Department of Cardiology   (Japan)

^k UNIVERSITY OF TOKYO   (Japan)

more..

Author keywords

coronary flow; ST segment elevation myocardial infarction; thrombectomy

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; CATHETER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE REPERFUSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOMES RESEARCH; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION; THROMBECTOMY; TIME; VACUUM ASPIRATION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; EMBOLISM; EQUIPMENT DESIGN; HUMANS; JAPAN; MYOCARDIAL INFARCTION; PATIENT SELECTION; PROSPECTIVE STUDIES; SUCTION; THROMBECTOMY; TIME FACTORS; TREATMENT OUTCOME;

EID: 49449091142     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2008.06.004     Document Type: Article

References (35)

1. Ito H., Tomooka T., Sakai N., et al. Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 85 (1992) 1699-1705
2. van't Hof A.W., Liem A., Suryapranata H., Hoorntje J.C., de Boer M.J., Zijlstra F., and Zwolle Myocardial Infarction Study Group. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Circulation 97 (1998) 2302-2306
3. Stone G.W., Peterson M.A., Lansky A.J., Dangas G., Mehran R., and Leon M.B. Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am Coll Cardiol 39 (2002) 591-597
4. Henriques J.P., Zijlstra F., Ottervanger J.P., et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J 23 (2002) 1112-1117
5. Wu K.C., Zerhouni E.A., Judd R.M., et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 97 (1998) 765-772
6. van 't Hof A.W., Liem A., de Boer M.J., Zijlstra F., and Zwolle Myocardial infarction Study Group. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Lancet 350 (1997) 615-619
7. Claeys M.J., Bosmans J., Veenstra L., Jorens P., De Raedt H., and Vrints C.J. Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome. Circulation 99 (1999) 1972-1977
8. Gabriel R.S., and White H.D. ExTRACT-TIMI 25 trial: clarifying the role of enoxaparin in patients with ST-elevation myocardial infarction receiving fibrinolysis. Expert Rev Cardiovasc Ther 5 (2007) 851-857
9. Sabatine M.S., McCabe C.H., Gibson C.M., and Cannon C.P. Design and rationale of Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis In Myocardial Infarction (CLARITY-TIMI) 28 trial. Am Heart J 149 (2005) 227-233
10. Ellis S.G., Armstrong P., Betriu A., et al., FINESSE Investigators. Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events (FINESSE) trial. Am Heart J 147 (2004) E16
11. Stone G.W., Webb J., Cox D.A., et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA 293 (2005) 1063-1072
12. Ali A., Cox D., Dib N., et al. Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study. J Am Coll Cardiol 48 (2006) 244-252
13. Kaltoft A., Bottcher M., Nielsen S.S., et al. Routine thrombectomy in percutaneous coronary intervention for acute ST-segment-elevation myocardial infarction: a randomized, controlled trial. Circulation 114 (2006) 40-47
14. Saber R.S., Edwards W.D., Bailey K.R., McGovern T.W., Schwartz R.S., and Holmes Jr. D.R. Coronary embolization after balloon angioplasty or thrombolytic therapy: an autopsy study of 32 cases. J Am Coll Cardiol 22 (1993) 1283-1288
15. Kloner R.A., Rude R.E., Carlson N., Maroko P.R., DeBoer L.W., and Braunwald E. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: which comes first?. Circulation 62 (1980) 945-952
16. Gavin J.B., Thomson R.W., Humphrey S.M., and Herdson P.B. Changes in vascular morphology associated with the no-reflow phenomenon in ischaemic myocardium. Virchows Arch A Pathol Anat Histopathol 399 (1983) 325-332
17. Michaels A.D., Gibson C.M., and Barron H.V. Microvascular dysfunction in acute myocardial infarction: focus on the roles of platelet and inflammatory mediators in the no-reflow phenomenon. Am J Cardiol 85 (2000) 50B-60B
18. Engler R.L., Dahlgren M.D., Morris D.D., Peterson M.A., and Schmid-Schonbein G.W. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol 251 (1986) H314-H323
19. Topol E.J., and Yadav J.S. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 101 (2000) 570-580
20. Sakurada M., Ikari Y., and Isshiki T. Improved performance of a new thrombus aspiration catheter: outcomes from in vitro experiments and a case presentation. Catheter Cardiovasc Interv 63 (2004) 299-306
21. Gibson C.M., Cannon C.P., Daley W.L., et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93 (1996) 879-888
22. Gibson C.M., Cannon C.P., Murphy S.A., et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 101 (2000) 125-130
23. Schroder R., Dissmann R., Bruggemann T., et al. Extent of early ST-segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction. J Am Coll Cardiol 24 (1994) 384-391
24. Schroder R., Wegscheider K., Schroder K., Dissmann R., and Meyer-Sabellek W. Extent of early ST-segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial. J Am Coll Cardiol 26 (1995) 1657-1664
25. Loubeyre C., Morice M.C., Lefevre T., Piechaud J.F., Louvard Y., and Dumas P. A randomized comparison of direct stenting with conventional stent implantation in selected patients with acute myocardial infarction. J Am Coll Cardiol 39 (2002) 15-21
26. Ito H., Maruyama A., Iwakura K., et al. Clinical implications of the "no reflow" phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 93 (1996) 223-228
27. Kotani J., Nanto S., Mintz G.S., et al. Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome. Circulation 106 (2002) 1672-1677
28. Silva-Orrego P., Colombo P., Bigi R., et al. Thrombus aspiration before primary angioplasty improves myocardial reperfusion in acute myocardial infarction: the DEAR-MI (Dethrombosis to Enhance Acute Reperfusion in Myocardial Infarction) study. J Am Coll Cardiol 48 (2006) 1552-1559
29. Lefevre T., Garcia E., Reimers B., et al. X-Sizer for thrombectomy in acute myocardial infarction improves ST-segment resolution: results of the X-Sizer in AMI for negligible embolization and optimal ST resolution (X AMINE ST) trial. J Am Coll Cardiol 46 (2005) 246-252
30. Stone G.W., Cox D.A., Low R., et al., X-tRACT Investigators. Safety and efficacy of a novel device for treatment of thrombotic and atherosclerotic lesions in native coronary arteries and saphenous vein grafts: results from the multicenter X-Sizer for treatment of thrombus and atherosclerosis in coronary applications trial (X-TRACT) study. Catheter Cardiovasc Interv 58 (2003) 419-427
31. Cohen R., Domniez T., Foucher R., Sfaxi A., and Elhadad S. Intracoronary thrombectomy with the export aspiration catheter before angioplasty in patients with ST-segment elevation myocardial infarction. J Interv Cardiol 20 (2007) 136-142
32. Antoniucci D., Valenti R., Migliorini A., et al. Comparison of rheolytic thrombectomy before direct infarct artery stenting versus direct stenting alone in patients undergoing percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 93 (2004) 1033-1035
33. Burzotta F., Trani C., Romagnoli E., et al. Manual thrombus-aspiration improves myocardial reperfusion: the randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial. J Am Coll Cardiol 46 (2005) 371-376
34. Cohen M., Gensini G.F., Maritz F., et al., TETAMI Investigators. Prospective evaluation of clinical outcomes after acute ST-elevation myocardial infarction in patients who are ineligible for reperfusion therapy: preliminary results from the TETAMI registry and randomized trial. Circulation 108 (2003) III14-III21
35. Stone G.W., Grines C.L., Cox D.A., et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 346 (2002) 957-966